Blue Bird Corporation logo BLBD - Blue Bird Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 11
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $89.00 DETAILS
HIGH: $95.00
LOW: $85.00
MEDIAN: $86.00
CONSENSUS: $89.00
UPSIDE: 46.99%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Cyclical & Capital-Intensive 80% confidence

Primary model: Normalized Earnings × Cycle Multiple

Valuation Signal Overvalued Strong
Trading 524.7% above fair value
Current Price $60.55
Bear Case $7.14 88.2% downside ($7.14 - $60.55) / $60.55 = -88.2% $1.02 × 7x
Fair Value $9.69 84.0% downside ($9.69 - $60.55) / $60.55 = -84.0% $1.02 × 10x
Bull Case $12.24 79.8% downside ($12.24 - $60.55) / $60.55 = -79.8% $1.02 × 12x

Adjust Assumptions

9.5x
1.02$

Key Value Driver

Through-cycle normalized EPS ($1.02)

Implied Market Multiple 59.4x

Plain-Language Summary

Using 7-year normalized EPS of $1.02 at a 10x cycle multiple, the base-case value is $9.69 per share. P/TBV cross-check: 9.8x.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (12 analysts) $89.00
Analyst Range $85.00 – $95.00
Divergence from AlphaVal 89%

Warnings

Recent profits ($3.88/share) are 280% above the mid-cycle average ($1.02). Buying based on peak profits is the most common mistake with boom-and-bust businesses.
Price-to-book value of 9.8x is above the normal range for this type of business (0.7x-2.0x). The stock may already price in a strong cycle.
Wall Street's average price target is $89.00 (from 12 analysts). Our estimate is 89% below the consensus -- consider that gap carefully.

Key Risks

  • Standard 10-year DCF produces unreliable terminal values for cyclicals
  • 'Cheap' P/E at cycle peak is the most common value trap — normalize first
  • Captive finance subsidiaries have different risk profiles from manufacturing